This study builds on a 2020 research study, conducted during the COVID-19 pandemic, which identified strategic opportunities to improve the health and well-being of the American population while reducing spending on likely avoidable hospitalizations. , emergency services and doctor visits up to $ 528 billion. dollars by optimizing the use of drugs and vaccines.
The study design calls for a balanced representation of the entire drug use ecosystem in the United States, including, but not limited to 11 stakeholder groups (e.g., advocates patients, physicians, nurses and clinicians, pharmacists and pharmacies, pharmaceutical manufacturers, healthcare systems, plans and plan sponsors, digital health and interoperability organizations, organizations standards and measures, government and policy leaders, and academic researchers).
Topics of study will include health equity and empowerment, value-driven payment and practice models, interoperability, digital technologies, measurement and attribution standards, adoption influenza and COVID-19 vaccine and national research priorities.
Judah Thornewill, PhD at UofL, Demetra Antimisiaris, PharmD, Robert Esterhay, MD, William Yasnoff, MD, PhD and Tom Walton, MDiv are the co-investigators of the study.
“We are excited to use new methods and tools based on scientific collaboration to enable leaders, experts and academics across the United States to co-create new concrete strategies to address this important human health challenge. population, ”Thornewill said.
For more information:
Learn more or apply to join the study at https://meds360.starstudy.link
The National Science Foundation Center for Health Organization Transformation at the University of Louisville (NSF-CHOT) is a federally-awarded industry-university collaborative research center that aims to accelerate applied research and workforce development. works by integrating health systems engineering, health services research and health. Politics. For more information, visit http://louisville.edu/sphis/departments/chot.
The RAPID Alliance is a multi-stakeholder, multi-university research consortium administered by NSF-CHOT and the Frazier Polypharmacy Program at UofL. Its mission is to conduct transformational research to optimize drug therapies for American populations. Founding members include leaders of the Patient Advocate Foundation (PAF), American Pharmacists Association (APhA), American Society of Health-System Pharmacists (ASHP), Academy of Managed Care Pharmacy (AMCP) , from the American Society of Consultant Pharmacists (ASCP), Association of Colleges of Pharmacy (AACP), National Alliance of State Pharmacy Associations (NASPA), National Association of Chain Drug Stores (NACDS), National Community Pharmacies Association (NCPA), the Community Pharmacy Foundation, CPESN USA, Sanofi and Sanofi Pasteur, and leading researchers from several schools of pharmacy and health science centers. For more information, visit www.rapidalliance.org.